These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 12044795)
1. Effect of low-affinity NMDA receptor antagonists on electrical activity in mouse cortical slices. Naish HJ; Marsh WL; Davies JA Eur J Pharmacol; 2002 May; 443(1-3):79-83. PubMed ID: 12044795 [TBL] [Abstract][Full Text] [Related]
2. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Popik P; Kozela E; Danysz W Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of N-methyl-D-aspartate-evoked currents in rat cortical cultures by ARL 15896AR. Mealing GA; Lanthorn TH; Small DL; Black MA; Laferriere NB; Morley P J Pharmacol Exp Ther; 1997 Apr; 281(1):376-83. PubMed ID: 9103520 [TBL] [Abstract][Full Text] [Related]
4. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Parsons CG; Danysz W; Bartmann A; Spielmanns P; Frankiewicz T; Hesselink M; Eilbacher B; Quack G Neuropharmacology; 1999 Jan; 38(1):85-108. PubMed ID: 10193901 [TBL] [Abstract][Full Text] [Related]
5. The low-affinity, use-dependent NMDA receptor antagonist AR-R 15896AR. An update of progress in stroke. Palmer GC; Cregan EF; Bialobok P; Sydserff SG; Hudzik TJ; McCarthy DJ Ann N Y Acad Sci; 1999; 890():406-20. PubMed ID: 10668446 [TBL] [Abstract][Full Text] [Related]
6. Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation. Parsons CG; Danysz W; Quack G Amino Acids; 2000; 19(1):157-66. PubMed ID: 11026484 [TBL] [Abstract][Full Text] [Related]
7. The lateral spread of epileptiform discharges in rat neocortical slices: effect of focal phencyclidine application. Gorji A; Scheller D; Speckmann EJ Pharmacopsychiatry; 2003 May; 36(3):113-20. PubMed ID: 12806569 [TBL] [Abstract][Full Text] [Related]
8. Effect of spermine and N1-dansyl-spermine on epileptiform activity in mouse cortical slices. Kirby BP; Shaw GG Eur J Pharmacol; 2005 Nov; 524(1-3):53-9. PubMed ID: 16253230 [TBL] [Abstract][Full Text] [Related]
9. Brain distribution of an uncompetitive NMDA receptor antagonist; comparison to its in vitro potency in electrophysiological studies. Hesselink MB; Parsons CG; Wollenburg C; Danysz W Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):144-50. PubMed ID: 10494883 [TBL] [Abstract][Full Text] [Related]
10. Greater contribution of N-methyl-D-aspartic acid receptors in ventral compared to dorsal hippocampal slices in the expression and long-term maintenance of epileptiform activity. Papatheodoropoulos C; Moschovos C; Kostopoulos G Neuroscience; 2005; 135(3):765-79. PubMed ID: 16154282 [TBL] [Abstract][Full Text] [Related]
11. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Kozela E; Danysz W; Popik P Eur J Pharmacol; 2001 Jun; 423(1):17-26. PubMed ID: 11438302 [TBL] [Abstract][Full Text] [Related]
12. Comparison of spontaneous and evoked epileptiform activity in three in vitro epilepsy models. Gulyás-Kovács A; Dóczi J; Tarnawa I; Détári L; Banczerowski-Pelyhe I; Világi I Brain Res; 2002 Aug; 945(2):174-80. PubMed ID: 12126879 [TBL] [Abstract][Full Text] [Related]
13. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia. Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017 [TBL] [Abstract][Full Text] [Related]
14. A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization. Gilling K; Jatzke C; Wollenburg C; Vanejevs M; Kauss V; Jirgensons A; Parsons CG J Neural Transm (Vienna); 2007; 114(12):1529-37. PubMed ID: 17728997 [TBL] [Abstract][Full Text] [Related]
15. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats. Zakharova ES; Danysz W; Bespalov AY Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308 [TBL] [Abstract][Full Text] [Related]
16. Low-affinity NMDA receptor antagonists. The neuroprotective potential of ARL 15896AR. Palmer GC; Miller JA; Cregan EF; Gendron P; Peeling J Ann N Y Acad Sci; 1997 Oct; 825():220-31. PubMed ID: 9369989 [No Abstract] [Full Text] [Related]
17. Glutamate receptor antagonists reduce spontaneous epileptiform activity in cortical wedges prepared from DBA/2 mice. Hu RQ; Davies JA Exp Brain Res; 1997 Jun; 115(2):311-8. PubMed ID: 9224858 [TBL] [Abstract][Full Text] [Related]
19. Spreading depression: imaging and blockade in the rat neocortical brain slice. Anderson TR; Andrew RD J Neurophysiol; 2002 Nov; 88(5):2713-25. PubMed ID: 12424306 [TBL] [Abstract][Full Text] [Related]